Vendor-neutral PFT reporting means your pulmonary function test software can accept, interpret, and report data from any spirometer or lung function device, regardless of who manufactured it. For labs running multiple devices from different vendors, this is not a convenience feature. It is the difference between a lab that scales and one that stays trapped by its own equipment choices.

TL;DR

• Vendor lock-in forces labs to duplicate data entry, accept software limitations, and restrict equipment purchasing decisions.

• Device-agnostic data import eliminates these constraints by creating a single reporting environment for all equipment.

• A single source of truth across devices reduces clinical risk, improves audit readiness, and simplifies compliance with evolving standards like race-neutral spirometry.

• Switching from legacy systems to a vendor-neutral platform is simpler than most labs expect.

• Rezibase is a cloud-based, manufacturer-agnostic respiratory and sleep reporting platform built specifically for clinical physiology labs.

What Does "Vendor-Neutral" Actually Mean in a PFT Context?

Vendor neutrality, in any technology context, refers to a platform's ability to integrate and work with tools from multiple manufacturers without preferencing or requiring any single one. As IXOPAY notes, vendor-agnostic companies prioritize flexibility to find the best solutions and avoid dependence on a single vendor.

In pulmonary function testing, this means:

• Importing raw test data from any spirometer, body plethysmograph, DLCO device, or oscillometry system

• Applying consistent normal values and interpretation algorithms regardless of the data source

• Producing standardized reports that reflect the lab's clinical standards, not the device manufacturer's template

The alternative, vendor-locked software, ties your reporting environment to one manufacturer's ecosystem. Change your equipment and you change your workflow, your data structure, and potentially your historical records.

Why Do Multi-Equipment Labs Struggle With Vendor-Locked PFT Software?

Most respiratory labs do not run a single device from a single manufacturer. Teaching hospitals and busy public labs often operate spirometers, body boxes, and diffusion capacity systems from two or three different vendors simultaneously. Vendor-locked software creates compounding problems in this environment:

Each of these problems compounds the others. A lab that cannot consolidate its data cannot easily demonstrate quality control, cannot efficiently onboard new staff, and cannot respond cleanly to accreditation reviews.

What Is a Single Source of Truth and Why Does It Matter for Lung Function Labs?

A single source of truth (SSoT) is a data architecture principle where one system holds the authoritative, unified record for a given domain. Cisco's white paper on network automation describes vendor-agnostic SSoT as best practice, noting it enables standardization of data models across diverse tools.

For a lung function lab, an SSoT means:

• Every test result, regardless of which device captured it, lives in one reporting environment

• Clinicians and scientists interpret from one consistent dataset

• Audit logs, quality control records, and patient histories are complete and accessible in one place

Without this, labs operate in a state of managed fragmentation. Data exists in multiple places, formatted differently, interpreted through different lenses.

How Does Race-Neutral Spirometry Compliance Fit Into This?

Spirometry interpretation is in the middle of a significant standards shift. As Vitalograph reported in January 2026, a new race-neutral model aims to eliminate the use of self-reported race and ethnicity as a variable in spirometry interpretation. This is a meaningful clinical and ethical change.

For vendor-locked labs, updating normal value sets across multiple separate systems is a manual, error-prone process. For a vendor-neutral platform with a centrally managed normal values library, it is a configuration update applied once, consistently, across all data sources.

This is one practical example where platform architecture directly affects clinical safety.

What Should Good Pulmonary Function Test Software Actually Do?

Beyond vendor neutrality, genuinely useful pulmonary function test software should address the full reporting workflow. Key capabilities worth evaluating include:

• Automated data extraction: Importing device reports and pulling discrete values, including flow-volume loops, without manual re-entry

• Guideline-aligned interpretation: Reporting structured around ATS guidelines, not manufacturer defaults

• Doctor-facing workflow tools: Structured report lists, medical dictation support, and AI-assisted report writing

• Normal values management: A pre-configured, regularly updated library that reflects current standards

• Quality control infrastructure: Westgard-method QC, non-conformance tracking, and audit readiness tools

• Accreditation support: Documentation management for standards like TSANZ/NATA and ISO 15189

Patient-reported outcomes are also becoming more relevant in device evaluation contexts. A 2022 study published in the Journal of Patient-Reported Outcomes examined the incorporation of patient-reported outcome instruments in medical device evaluations over a six-year period, reflecting a broader shift toward patient-centered measurement in clinical technology. Software that can accommodate this direction is better positioned for the future.

Is Switching From an Existing System Really That Straightforward?

This is the question most labs avoid asking because they assume the answer is painful. In practice, moving from a legacy or vendor-locked system to a modern platform is more manageable than it looks, particularly when the new platform is designed with migration in mind.

A structured transition typically involves:

1. Audit your current data: Identify what needs to move and in what format

2. Map your workflows: Understand which processes are device-dependent versus lab-defined

3. Import historical records: A well-designed platform handles this as a guided process, not a technical project

4. Configure normal values and templates: Set once, apply consistently

5. Train staff on the new environment: Cloud-based platforms reduce this burden significantly since there is nothing to install locally

Rezibase's Magic Import feature is built specifically to handle this transition point, accepting device reports directly and extracting discrete data automatically. Labs moving from systems like Respiro to Rezibase find that the data migration process is a guided, straightforward step rather than a barrier.

Frequently Asked Questions

What is vendor-neutral PFT reporting?
It means your reporting software accepts data from any lung function device, regardless of manufacturer, and produces consistent reports from a single platform.

Can a vendor-neutral platform handle both respiratory and sleep data?
Yes. Platforms like Rezibase are designed to cover both respiratory and sleep lab workflows in one environment.

Does switching platforms mean losing historical patient data?
Not with a well-designed migration process. Historical records can be imported and consolidated into the new system.

How does device-agnostic import reduce clinical risk?
By eliminating manual data re-entry between systems, it removes a primary source of transcription errors and inconsistencies.

Is cloud-based PFT software secure enough for hospital environments?
Enterprise-grade cloud platforms can be deployed on-premises where required and are designed to meet hospital security and integration requirements, including PAS and EMR connectivity.

How does a vendor-neutral platform handle normal value updates like the race-neutral spirometry change?
A centrally managed normal values library means updates are applied once and reflected consistently across all device data sources.

What accreditation standards should PFT software support?
Look for platforms that support TSANZ/NATA standards and ISO 15189 requirements, including document management, QC, and audit trail capabilities.

About Rezibase

Rezibase is a cloud-based respiratory and sleep reporting platform built by respiratory scientists for clinical physiology labs. Manufacturer-agnostic by design, it supports labs across Australia, New Zealand, the UK, and Ireland, including NHS and NSW Health sites, with a comprehensive suite covering reporting, accreditation, quality control, and full lab administration. Learn more at rezibase.com.

Ready to see what a vendor-neutral reporting environment looks like in practice? Explore Rezibase at rezibase.com or get in touch to arrange a demonstration.

References

• IXOPAY. Vendor Agnostic Platforms: How Becoming Vendor Neutral Changes the Game. https://www.ixopay.com/blog/vendor-agnostic-platforms-how-becoming-vendor-neutral-changes-the-game

• Cisco. Single Source of Truth in Network Automation White Paper. https://www.cisco.com/c/en/us/solutions/collateral/executive-perspectives/technology-perspectives/ssot-nw-automation-wp.html

• Vitalograph. The Shift Toward Race-Neutral Spirometry. https://vitalograph.com/vital-insights/respiratory-insights/the-shift-toward-race-neutral-spirometry

• Matts ST et al. Inclusion of patient-reported outcome instruments in US FDA medical device marketing authorizations. https://link.springer.com/article/10.1186/s41687-022-00444-z